These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38752802

  • 1. Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines.
    Wanlapakorn N, Sarawanangkoor N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2352909. PubMed ID: 38752802
    [Abstract] [Full Text] [Related]

  • 2. A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants.
    Elenge DM, Heo JS, Kim SS, Kim YK, Lee JH, Xavier S, Bahar E, Dos Santos G, Guignard A.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2406060. PubMed ID: 39376187
    [Abstract] [Full Text] [Related]

  • 3. Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule.
    Martinón-Torres F, Salamanca de la Cueva I, Horn M, Westerholt S, Bosis S, Meyer N, Cheuvart B, Virk N, Jakes RW, Duchenne M, Van den Steen P.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2342630. PubMed ID: 38687024
    [Abstract] [Full Text] [Related]

  • 4. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
    Guerra A, Costantino C, Martinon-Torres F, Westerholt S, Lambeth C, Chen Z, Lumley J, Marcek T, Johnson D, Wilck M.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2310900. PubMed ID: 38327239
    [Abstract] [Full Text] [Related]

  • 5. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.
    Hum Vaccin Immunother; 2014 Dec 31; 10(10):2795-8. PubMed ID: 25483640
    [Abstract] [Full Text] [Related]

  • 6. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N, Maertens K, Thongmee T, Srimuan D, Thatsanathorn T, Van Damme P, Leuridan E, Poovorawan Y.
    Vaccine; 2020 Oct 14; 38(44):6914-6921. PubMed ID: 32888740
    [Abstract] [Full Text] [Related]

  • 7. Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study.
    Zhu Y, Sun L, Wang Y, Wang J, Wang Y, Li J, Wang L, Guo Y.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2372884. PubMed ID: 38957938
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R.
    Eur J Pediatr; 1998 Mar 31; 157(3):208-14. PubMed ID: 9537487
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan.
    Nakayama T, Vidor E, Tsuzuki D, Nishina S, Sasaki T, Ishii Y, Mizukami H, Tsuge H.
    J Infect Chemother; 2020 Jul 31; 26(7):651-659. PubMed ID: 32307307
    [Abstract] [Full Text] [Related]

  • 11. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, McIntyre P, Menzies R.
    Commun Dis Intell Q Rep; 2013 Dec 31; 37 Suppl():S1-95. PubMed ID: 24410428
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age.
    Wanlapakorn N, Pruetarat N, Sarawanangkoor N, Phanphanit K, Srimuan D, Thatsanathorn T, Thongmee T, Posuwan N, Poovorawan Y.
    Vaccine; 2023 Jun 13; 41(26):3855-3861. PubMed ID: 37202270
    [Abstract] [Full Text] [Related]

  • 13. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L.
    Pediatrics; 1999 Jan 13; 103(1):25-30. PubMed ID: 9917435
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama.
    Calvo AE, Tristán Urrutia AG, Vargas-Zambrano JC, López Castillo H.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2389577. PubMed ID: 39164002
    [Abstract] [Full Text] [Related]

  • 16. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
    Martinón-Torres F, Halperin SA, Nolan T, Tapiéro B, Perrett KP, de la Cueva IS, García-Sicilia J, Stranak Z, Vanderkooi OG, Kosina P, Rumlarova S, Virta M, Arribas JMM, Miranda-Valdivieso M, Novas BA, Bozensky J, Ortega MJC, Amador JTR, Baca M, Palomino EE, Zuccotti GV, Janota J, Marchisio PG, Kostanyan L, Meyer N, Ceregido MA, Cheuvart B, Kuriyakose SO, Mesaros N.
    Vaccine; 2021 Mar 12; 39(11):1598-1608. PubMed ID: 33612341
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India.
    Khan T, Das RS, Jana M, Bhattacharya SD, Halder S, Ray S, Satpathi P, Ghosh T, Mukherjee K, Choudhury SP.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2383030. PubMed ID: 39082142
    [Abstract] [Full Text] [Related]

  • 18. Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China.
    Huang A, Xu X, Tang L, Huang L, Li J, Zhang X, Liu J, Zhou Y, Zhang B, Wang L, Zhang Q, Zhou Z, Wang Y, Wang X, Liu Q, Liu S, Yin Z, Wang F.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2333098. PubMed ID: 38619056
    [Abstract] [Full Text] [Related]

  • 19. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M, Zambrano B, Santos-Lima E.
    Pediatr Infect Dis J; 2012 Jan 31; 31(1):e24-30. PubMed ID: 22157567
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.
    Greenberg DP, Doemland M, Bettinger JA, Scheifele DW, Halperin SA, IMPACT Investigators, Waters V, Kandola K.
    Pediatr Infect Dis J; 2009 Jun 31; 28(6):521-8. PubMed ID: 19436236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.